1. Home
  2. RGEN vs DSGX Comparison

RGEN vs DSGX Comparison

Compare RGEN & DSGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • DSGX
  • Stock Information
  • Founded
  • RGEN 1981
  • DSGX 1981
  • Country
  • RGEN United States
  • DSGX Canada
  • Employees
  • RGEN N/A
  • DSGX N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • DSGX Computer Software: Prepackaged Software
  • Sector
  • RGEN Health Care
  • DSGX Technology
  • Exchange
  • RGEN Nasdaq
  • DSGX Nasdaq
  • Market Cap
  • RGEN 8.2B
  • DSGX 8.5B
  • IPO Year
  • RGEN N/A
  • DSGX 1999
  • Fundamental
  • Price
  • RGEN $146.70
  • DSGX $96.21
  • Analyst Decision
  • RGEN Buy
  • DSGX Buy
  • Analyst Count
  • RGEN 10
  • DSGX 11
  • Target Price
  • RGEN $188.38
  • DSGX $102.27
  • AVG Volume (30 Days)
  • RGEN 899.5K
  • DSGX 131.0K
  • Earning Date
  • RGEN 10-29-2024
  • DSGX 09-04-2024
  • Dividend Yield
  • RGEN N/A
  • DSGX N/A
  • EPS Growth
  • RGEN N/A
  • DSGX 13.00
  • EPS
  • RGEN N/A
  • DSGX 1.48
  • Revenue
  • RGEN $602,354,000.00
  • DSGX $607,697,000.00
  • Revenue This Year
  • RGEN $0.08
  • DSGX $8.59
  • Revenue Next Year
  • RGEN $12.97
  • DSGX $3.88
  • P/E Ratio
  • RGEN N/A
  • DSGX $65.05
  • Revenue Growth
  • RGEN N/A
  • DSGX 15.40
  • 52 Week Low
  • RGEN $110.45
  • DSGX $69.59
  • 52 Week High
  • RGEN $211.13
  • DSGX $104.71
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 48.16
  • DSGX 42.95
  • Support Level
  • RGEN $139.41
  • DSGX $92.85
  • Resistance Level
  • RGEN $150.72
  • DSGX $97.64
  • Average True Range (ATR)
  • RGEN 5.22
  • DSGX 2.22
  • MACD
  • RGEN -0.94
  • DSGX -0.51
  • Stochastic Oscillator
  • RGEN 50.59
  • DSGX 36.96

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About DSGX Descartes Systems Group Inc. (The)

Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.

Share on Social Networks: